Toshiba Installs Milestone 500th Vantage 1.5T MR System at Jefferson Regional Medical Center
|
|
March 24, 2008 -- TUSTIN, Calif. --
Toshiba Installs Milestone 500th Vantage 1.5T MR System at Jefferson
Regional Medical Center
Vantage Image Quality, Patient Comfort and Contrast-Free Techniques Highlight
Purchase Decision
Toshiba America Medical Systems, Inc., an industry leader in magnetic resonance
(MR) technology, reached a significant achievement in installing its
500th VantageTM 1.5T MR system at Jefferson Regional Medical Center
(JRMC) in Pine Bluff, Ark. JRMC will use the Vantage system for a variety
of diagnostic procedures including orthopedic, head and abdomen imaging.
JRMC’s Radiology Department was upgrading its MR equipment as a way to continue to provide the highest level of patient care. The Vantage’s bore size and high homogeneity were key factors in selecting the Vantage.
“The Vantage’s high image quality and patient-focused features were important qualities when upgrading our equipment,” stated John Stansbury, director of Medical Imaging at JRMC. “Toshiba’s
Vantage MR system was quieter than other systems on the market
and noise is a significant reason for patient discomfort when undergoing
an MR. Also, the image quality on the Vantage is fantastic and
provides our physicians with the best images for accurate diagnoses.”
Toshiba's
Vantage MR |
|
Toshiba’s patented Pianissimo™ technology,
which reduces acoustic noise by as much as 90 percent, eliminates
most patient nervousness and dissatisfaction associated with
MR exams. The system’s integrated coil concept allows physicians
to perform multiple exams without repositioning the patient.
This means a more comfortable exam experience and results in
enhanced workflow and technologist productivity.
Also, Toshiba’s
SPEEDER parallel imaging allows for increased acquisition speed
and reduced examination times. |
“Installing the 500th Vantage MR system speaks volumes about the industry’s response to the product and our commitment to image quality and patient care,” said Bob Giegerich, director, MR Business Unit, Toshiba. “The
Vantage system meets clinical demands and delivers high-resolution images across
the entire body with faster imaging times.”
Finally, JRMC was also interested in Toshiba’s proprietary, contrast-free MRA techniques – Fresh
Blood Imaging (FBI), Contrast-free Improved Angiography (CIA), Time-Spatial Labeling
Inversion Pulse (Time-SLIP) and Time and Space Angiography (TSA). These techniques
are available on all Toshiba MR systems. Contrast-free imaging is particularly
important because gadolinium, the most common contrast agent used for magnetic
resonance imaging (MRI) and magnetic resonance angiography (MRA) exams, has been
directly linked to a sometimes fatal disease that occurs in patients with renal
insufficiency, called Nephrogenic Systemic Fibrosis (NSF) or Nephrogenic Fibrosing
Dermopathy (NFD).
Toshiba’s Vantage product was named Best in KLAS in 2007 and 2006. It also holds
the number one rating with MD Buyline.
About Toshiba
With headquarters in Tustin, Calif., Toshiba America Medical
Systems markets, sells, distributes and services diagnostic
imaging systems, and coordinates clinical diagnostic imaging
research for all modalities in the United States. Toshiba
Medical Systems Corp., an independent group company of Toshiba
Corp., is a global leading provider of diagnostic medical
imaging systems and comprehensive medical solutions, such
as CT, Cath & EP Labs, X-ray, Ultrasound, Nuclear Medicine,
MRI and information systems. Toshiba Corp. is a leader in
information and communications systems, electronic components,
consumer products, and power systems. Toshiba has approximately
191,000 employees worldwide and annual sales of $60 billion.
For more information, visit www.medical.toshiba.com.
Source: Toshiba
America Medical Systems
|